ACRV
Acrivon Therapeutics, Inc.
Company overview
- Market capitalization
- $88.28M
- Employees
- 74
- Latest publication
- 2026-09-29
About Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 for the treatment of patients with endometrial and platinum-resistant ovarian cancer, and SCCs, such as SCCHN and anal cancer. The company is also developing ACR-2316, a dual WEE1 and PKMYT1 inhibitor small molecule candidate; and a preclinical stage AP3-and co-crystallography-based preclinical cell cycle program. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 848,000USD | 0USD | 0USD |
| Cost Of Revenue | 383,000USD | -911,000USD | 300,000USD | 300,000USD | 311,000USD | 303,000USD | 300,000USD | 200,000USD |
| Gross Profit | -383,000USD | 911,000USD | -300,000USD | -300,000USD | -311,000USD | -303,000USD | -300,000USD | -200,000USD |
| Research Development | 14,783,000USD | 15,046,000USD | 13,648,000USD | 16,182,000USD | 15,414,000USD | 18,327,000USD | 18,864,000USD | 15,025,000USD |
| Selling General Administrative | 4,736,000USD | 5,370,000USD | 6,039,000USD | 6,467,000USD | 6,248,000USD | 6,324,000USD | 6,276,000USD | 6,412,000USD |
| Total Operating Expenses | 19,519,000USD | 21,027,000USD | 19,687,000USD | 22,349,000USD | 21,351,000USD | 24,651,000USD | 25,140,000USD | 21,437,000USD |
| Operating Income | -19,902,000USD | -20,116,000USD | -19,687,000USD | -22,649,000USD | -21,662,000USD | -24,954,000USD | -25,140,000USD | -21,437,000USD |
| Interest Income | 989,000USD | 1,247,000USD | 1,506,000USD | 1,730,000USD | 1,996,000USD | 2,363,000USD | 2,698,000USD | 2,694,000USD |
| Net Interest Income | 989,000USD | 1,247,000USD | 1,506,000USD | 1,730,000USD | 1,996,000USD | 2,363,000USD | 2,698,000USD | 2,694,000USD |
| Income Before Tax | -19,042,000USD | -18,985,000USD | -18,234,000USD | -21,006,000USD | -19,680,000USD | -22,831,000USD | -22,441,000USD | -18,798,000USD |
| Net Income | -19,042,000USD | -18,985,000USD | -18,234,000USD | -21,006,000USD | -19,680,000USD | -22,831,000USD | -22,441,000USD | -18,798,000USD |
| Net Income From Continuing Ops | -19,042,000USD | -18,985,000USD | -18,234,000USD | -21,006,000USD | -19,680,000USD | -22,831,000USD | -22,441,000USD | -18,798,000USD |
| Ebit | -19,902,000USD | -25,194,000USD | -19,687,000USD | -21,006,000USD | -19,680,000USD | -22,831,000USD | -25,140,000USD | -21,437,000USD |
| Ebitda | -19,519,000USD | -26,105,000USD | -19,338,000USD | -20,706,000USD | -19,369,000USD | -22,528,000USD | -24,889,000USD | -21,209,000USD |
| Depreciation And Amortization | 383,000USD | -911,000USD | 349,000USD | 300,000USD | 311,000USD | 303,000USD | 251,000USD | 228,000USD |
| Reconciled Depreciation | 383,000USD | 361,000USD | 349,000USD | 335,000USD | 311,000USD | 303,000USD | 251,000USD | 228,000USD |
| Total Other Income Expense Net | 860,000USD | 1,131,000USD | 1,453,000USD | 1,643,000USD | 1,982,000USD | 2,123,000USD | 2,699,000USD | 2,639,000USD |
| Income Tax Expense | — | — | — | — | — | -180,724USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 1,356,000USD | 1,006,000USD | 536,000USD | 1,095,000USD | 832,000USD | 13,000USD |
| Gross Profit | -1,356,000USD | -1,006,000USD | -536,000USD | -1,095,000USD | -832,000USD | -13,000USD |
| Research Development | 59,990,000USD | 63,992,000USD | 45,488,000USD | 23,949,000USD | 13,718,000USD | 1,870,000USD |
| Selling General Administrative | 24,124,000USD | 25,207,000USD | 21,079,000USD | 8,708,000USD | 2,466,000USD | 1,298,000USD |
| Unclassified Operating Expenses | -1,356,000USD | -1,006,000USD | — | — | — | — |
| Total Operating Expenses | 82,758,000USD | 88,193,000USD | 66,701,000USD | 32,657,000USD | 16,184,000USD | 3,168,000USD |
| Operating Income | -84,114,000USD | -89,199,000USD | -67,237,000USD | -32,657,000USD | -16,184,000USD | -3,168,000USD |
| Interest Income | 6,479,000USD | 9,201,000USD | 7,037,000USD | — | — | — |
| Net Interest Income | 6,479,000USD | 9,201,000USD | 7,037,000USD | — | — | — |
| Income Before Tax | -77,905,000USD | -80,556,000USD | -60,388,000USD | -31,167,000USD | -16,243,000USD | -5,306,000USD |
| Net Income | -77,905,000USD | -80,556,000USD | -60,388,000USD | -29,677,000USD | -16,243,000USD | -5,306,000USD |
| Net Income From Continuing Ops | -77,905,000USD | -80,556,000USD | -50,065,000USD | -31,167,000USD | -16,243,000USD | -5,306,000USD |
| Ebit | -84,114,000USD | -80,556,000USD | -60,388,000USD | -32,657,000USD | -16,184,000USD | -5,306,000USD |
| Ebitda | -82,758,000USD | -79,550,000USD | -59,852,000USD | -32,293,000USD | -16,147,000USD | -5,293,000USD |
| Depreciation And Amortization | 1,356,000USD | 1,006,000USD | 536,000USD | 364,000USD | 37,000USD | 13,000USD |
| Reconciled Depreciation | 1,356,000USD | 1,006,000USD | 512,000USD | 364,000USD | 37,000USD | 13,000USD |
| Total Other Income Expense Net | 6,209,000USD | 8,643,000USD | 6,849,000USD | 1,490,000USD | -59,000USD | -2,138,000USD |
| Selling And Marketing Expenses | — | — | 134,000USD | — | — | — |
| Income Tax Expense | — | — | 1USD | -1,490,000USD | -199,558USD | -193,297USD |
| Interest Expense | — | — | — | 1,490,000USD | 59,000USD | — |
| Non Operating Income Net Other | — | — | — | 1,490,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -31,167,000USD | -16,243,000USD | -5,306,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 99,092,000USD | 107,832,000USD | 129,717,000USD | 145,299,000USD | 158,583,000USD | 176,349,000USD | 196,588,000USD | 214,684,000USD |
| Cash And Equivalents | 41,417,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 89,959,000USD | 97,737,000USD | 118,582,000USD | 129,254,000USD | 137,423,000USD | 149,635,000USD | 179,480,000USD | 187,453,000USD |
| Short Term Investments | 48,542,000USD | 63,673,000USD | 77,083,000USD | 93,849,000USD | 95,528,000USD | 110,481,000USD | 139,662,000USD | 144,038,000USD |
| Total Current Assets | 91,493,000USD | 99,220,000USD | 120,445,000USD | 130,361,000USD | 138,412,000USD | 151,327,000USD | 181,629,000USD | 188,984,000USD |
| Other Current Assets | 1,534,000USD | 1,483,000USD | 1,863,000USD | 1,107,000USD | 989,000USD | 1,692,000USD | 2,149,000USD | 1,531,000USD |
| Other Non Current Assets | 1,179,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 12,427,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 11,447,000USD | 11,054,000USD | 15,664,000USD | 14,891,000USD | 13,431,000USD | 13,550,000USD | 17,214,000USD | 14,819,000USD |
| Total Stockholder Equity | 86,665,000USD | 95,515,000USD | 112,516,000USD | 128,603,000USD | 143,037,000USD | 160,390,000USD | 176,786,000USD | 196,892,000USD |
| Total Equity Including Noncontrolling Interest | 86,665,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 6,225,000USD | 6,908,000USD | 7,416,000USD | 7,981,000USD | 8,124,000USD | 7,982,000USD | 8,025,000USD | 8,467,000USD |
| Accounts Payable | 861,000USD | 1,162,000USD | 2,277,000USD | 996,000USD | 1,163,000USD | 3,691,000USD | 758,000USD | 1,506,000USD |
| Short Term Debt | 1,135,000USD | 1,152,000USD | 1,172,000USD | 1,184,000USD | 1,148,000USD | 1,105,000USD | 1,057,000USD | 1,040,000USD |
| Common Stock | 42,000USD | 38,000USD | 31,000USD | 31,000USD | 31,000USD | 31,000USD | 31,000USD | 31,000USD |
| Retained Earnings | -311,887,000USD | -293,923,000USD | -274,881,000USD | -255,896,000USD | -237,662,000USD | -216,656,000USD | -196,976,000USD | -174,145,000USD |
| Accumulated Other Comprehensive Income | -33,000USD | 4,000USD | 111,000USD | 112,000USD | 106,000USD | 283,000USD | 447,000USD | 782,000USD |
| Total Liab | — | 12,317,000USD | 17,201,000USD | 16,696,000USD | 15,546,000USD | 15,959,000USD | 19,802,000USD | 17,792,000USD |
| Other Current Liab | — | 8,740,000USD | 12,215,000USD | 12,711,000USD | 11,120,000USD | 8,754,000USD | 15,399,000USD | 12,273,000USD |
| Capital Stock | — | 38,000USD | 31,000USD | 31,000USD | 31,000USD | 31,000USD | 31,000USD | 31,000USD |
| Cash | — | 34,064,000USD | 41,499,000USD | 35,405,000USD | 41,895,000USD | 39,154,000USD | 39,818,000USD | 43,415,000USD |
| Net Debt | — | -31,649,000USD | -38,790,000USD | -32,416,000USD | -38,632,000USD | -35,640,000USD | -36,173,000USD | -39,402,000USD |
| Short Long Term Debt Total | — | 2,415,000USD | 2,709,000USD | 2,989,000USD | 3,263,000USD | 3,514,000USD | 3,645,000USD | 4,013,000USD |
| Property Plant Equipment Gross | — | 10,609,000USD | 10,734,000USD | 10,938,000USD | 10,732,000USD | 10,255,000USD | 9,987,000USD | 10,126,000USD |
| Common Stock Shares Outstanding | — | 38,724,803shares | 38,509,281shares | 38,560,464shares | 38,461,619shares | 38,350,444shares | 38,242,412shares | 38,105,131shares |
| Non Current Assets Total | — | 8,612,000USD | 9,272,000USD | 14,938,000USD | 20,171,000USD | 25,022,000USD | 14,959,000USD | 25,700,000USD |
| Non Current Liabilities Total | — | 1,263,000USD | 1,537,000USD | 1,805,000USD | 2,115,000USD | 2,409,000USD | 2,588,000USD | 2,973,000USD |
| Non Currrent Assets Other | — | 1,704,000USD | 1,856,000USD | 1,849,000USD | 1,848,000USD | 1,845,000USD | 1,845,000USD | 1,843,000USD |
| Net Working Capital | — | 88,166,000USD | 104,781,000USD | 115,470,000USD | 124,981,000USD | 137,777,000USD | 164,415,000USD | 174,165,000USD |
| Unclassified Non Current Liabilities | — | 1,263,000USD | 1,537,000USD | 1,805,000USD | 2,115,000USD | 2,409,000USD | 2,588,000USD | 2,973,000USD |
| Unclassified Equity | — | 389,358,000USD | 387,224,000USD | 384,325,000USD | 380,531,000USD | 376,701,000USD | 373,253,000USD | 370,193,000USD |
| Long Term Investments | — | — | 0USD | 5,108,000USD | 10,199,000USD | 15,195,000USD | 5,089,000USD | 15,390,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 129,717,000USD | 196,588,000USD | 138,265,000USD | 181,226,000USD | 106,587,000USD | 2,185,000USD |
| Other Current Assets | 1,863,000USD | 2,149,000USD | 2,234,000USD | 4,344,000USD | 805,000USD | 136,000USD |
| Total Liab | 17,201,000USD | 19,802,000USD | 17,070,000USD | 10,751,000USD | 130,396,000USD | 10,598,000USD |
| Total Stockholder Equity | 112,516,000USD | 176,786,000USD | 121,195,000USD | 170,475,000USD | -23,809,000USD | -8,413,000USD |
| Other Current Liab | 12,215,000USD | 15,399,000USD | 7,378,000USD | 4,817,000USD | 1,220,000USD | 419,000USD |
| Common Stock | 31,000USD | 31,000USD | 23,000USD | 22,000USD | 2,000USD | 1,000USD |
| Capital Stock | 31,000USD | 31,000USD | 23,000USD | 22,000USD | 2,000USD | 1,000USD |
| Retained Earnings | -274,881,000USD | -196,976,000USD | -116,420,000USD | -56,032,000USD | -24,865,000USD | -8,622,000USD |
| Cash | 41,499,000USD | 39,818,000USD | 36,015,000USD | 29,519,000USD | 99,603,000USD | 1,583,000USD |
| Cash And Short Term Investments | 118,582,000USD | 179,480,000USD | 127,458,000USD | 127,751,000USD | 99,603,000USD | 1,583,000USD |
| Total Current Assets | 120,445,000USD | 181,629,000USD | 129,692,000USD | 132,095,000USD | 100,408,000USD | 1,719,000USD |
| Total Current Liabilities | 15,664,000USD | 17,214,000USD | 13,303,000USD | 6,516,000USD | 2,914,000USD | 613,000USD |
| Net Debt | -38,790,000USD | -36,173,000USD | -31,371,000USD | -24,558,000USD | -93,975,000USD | -1,525,000USD |
| Short Term Debt | 1,172,000USD | 1,057,000USD | 877,000USD | 726,000USD | 664,000USD | 58,000USD |
| Short Long Term Debt Total | 2,709,000USD | 3,645,000USD | 4,644,000USD | 4,961,000USD | 5,628,000USD | 58,000USD |
| Long Term Investments | 0USD | 5,089,000USD | 0USD | 41,881,000USD | 0USD | — |
| Short Term Investments | 77,083,000USD | 139,662,000USD | 91,443,000USD | 98,232,000USD | 0USD | — |
| Accounts Payable | 2,277,000USD | 758,000USD | 5,048,000USD | 904,000USD | 964,000USD | 136,000USD |
| Property Plant Equipment Net | 7,416,000USD | 8,025,000USD | 7,908,000USD | 6,862,000USD | 5,791,000USD | 59,000USD |
| Property Plant Equipment Gross | 10,734,000USD | 9,987,000USD | 8,864,000USD | 7,282,000USD | 5,847,000USD | 78,000USD |
| Accumulated Other Comprehensive Income | 111,000USD | 447,000USD | -83,000USD | -95,000USD | — | — |
| Common Stock Shares Outstanding | 38,509,281shares | 38,296,428shares | 22,078,190shares | 21,920,634shares | 12,909,823shares | 12,909,823shares |
| Non Current Assets Total | 9,272,000USD | 14,959,000USD | 8,573,000USD | 49,131,000USD | 6,179,000USD | 466,000USD |
| Non Current Liabilities Total | 1,537,000USD | 2,588,000USD | 3,767,000USD | 4,235,000USD | 127,482,000USD | 9,985,000USD |
| Non Currrent Assets Other | 1,856,000USD | 1,845,000USD | 665,000USD | 388,000USD | 388,000USD | 407,000USD |
| Net Working Capital | 104,781,000USD | 164,415,000USD | 116,389,000USD | 125,579,000USD | 97,494,000USD | 1,106,000USD |
| Unclassified Non Current Liabilities | 1,537,000USD | 2,588,000USD | 3,767,000USD | — | 127,482,000USD | 9,985,000USD |
| Unclassified Equity | 387,224,000USD | 373,253,000USD | 237,652,000USD | 226,558,000USD | 1,052,000USD | — |
| Other Assets | — | — | 1USD | 388,000USD | 388,000USD | 407,000USD |
| Current Deferred Revenue | — | — | — | 69,000USD | 66,000USD | — |
| Non Current Liabilities Other | — | — | — | 4,235,000USD | — | — |
| Net Tangible Assets | — | — | — | 170,475,000USD | -23,809,000USD | -8,413,000USD |
| Short Long Term Debt | — | — | — | — | — | 58,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -19,042,000USD | -18,985,000USD | -18,234,000USD | -21,006,000USD | -19,680,000USD | -22,831,000USD | -22,441,000USD | -18,798,000USD |
| Depreciation | 383,000USD | 361,000USD | 300,000USD | 162,000USD | 311,000USD | 303,000USD | 300,000USD | 200,000USD |
| Stock Based Compensation | 2,181,000USD | 3,091,000USD | 3,911,000USD | 3,927,000USD | 3,791,000USD | 3,707,000USD | 3,671,000USD | 3,566,000USD |
| Other Non Cash Items | 2,615,000USD | 395,000USD | 4,185,000USD | 255,000USD | -112,000USD | -654,000USD | 2,654,000USD | 2,724,000USD |
| Change In Working Capital | -4,494,000USD | -99,000USD | 1,466,000USD | 52,000USD | -3,845,000USD | 2,115,000USD | 2,164,000USD | 1,971,000USD |
| Total Cash From Operating Activities | -20,538,000USD | -15,237,000USD | -12,283,000USD | -16,610,000USD | -19,535,000USD | -17,360,000USD | -17,323,000USD | -13,903,000USD |
| Capital Expenditures | -14,000USD | -219,000USD | -899,000USD | -493,000USD | -58,000USD | -827,000USD | -989,000USD | -137,000USD |
| Free Cash Flow | -20,552,000USD | -15,456,000USD | -13,182,000USD | -17,103,000USD | -19,593,000USD | -18,187,000USD | -18,312,000USD | -14,040,000USD |
| Investments | 13,141,000USD | 21,743,000USD | 5,911,000USD | 19,451,000USD | 19,214,000USD | 14,412,000USD | 16,011,000USD | -88,044,000USD |
| Total Cashflows From Investing Activities | 13,127,000USD | 21,524,000USD | 5,911,000USD | 19,451,000USD | 19,214,000USD | 14,412,000USD | 16,011,000USD | -88,044,000USD |
| Total Cash From Financing Activities | -33,000USD | -192,000USD | -117,000USD | -97,000USD | -343,000USD | -647,000USD | -1,504,000USD | 123,350,000USD |
| Change In Cash | -7,435,000USD | 6,095,000USD | -6,490,000USD | 2,744,000USD | -664,000USD | -3,595,000USD | -2,591,000USD | 21,399,000USD |
| Begin Period Cash Flow | 41,499,000USD | 35,607,000USD | 41,895,000USD | 39,352,000USD | 40,016,000USD | 43,611,000USD | 46,006,000USD | 24,607,000USD |
| End Period Cash Flow | 34,064,000USD | 41,702,000USD | 35,405,000USD | 42,096,000USD | 39,352,000USD | 40,016,000USD | 43,415,000USD | 46,006,000USD |
| Other Cashflows From Financing Activities | -33,000USD | -192,000USD | -117,000USD | -97,000USD | -344,000USD | -647,000USD | -1,197,000USD | -510,000USD |
| Unclassified Operating Cash Flow | -2,181,000USD | — | -3,911,000USD | — | — | — | -3,671,000USD | -3,566,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | — | — | 0USD | 0USD | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | — | 123,860,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -77,905,000USD | -80,556,000USD | -60,388,000USD | -31,167,000USD | -16,243,000USD | -5,306,000USD |
| Depreciation | 919,000USD | 1,006,000USD | 536,000USD | 364,000USD | 37,000USD | 13,000USD |
| Stock Based Compensation | 14,720,000USD | 14,288,000USD | 11,618,000USD | 2,185,000USD | 497,000USD | 3,000USD |
| Other Non Cash Items | 1,027,000USD | -2,845,000USD | 1,064,000USD | 33,000USD | 1,399,000USD | 2,170,000USD |
| Change In Working Capital | -2,426,000USD | 2,438,000USD | 8,138,000USD | -1,532,000USD | 328,000USD | 317,000USD |
| Total Cash From Operating Activities | -63,665,000USD | -65,669,000USD | -42,641,000USD | -30,117,000USD | -13,982,000USD | -2,803,000USD |
| Capital Expenditures | -1,669,000USD | -2,768,000USD | -1,288,000USD | -2,166,000USD | -238,000USD | -15,000USD |
| Free Cash Flow | -65,334,000USD | -68,437,000USD | -43,929,000USD | -32,283,000USD | -14,220,000USD | -2,818,000USD |
| Investments | 67,769,000USD | -51,771,000USD | -64,886,000USD | -139,510,000USD | -238,000USD | -15,000USD |
| Total Cashflows From Investing Activities | 66,100,000USD | -51,771,000USD | 50,717,000USD | -141,676,000USD | -238,000USD | -15,000USD |
| Total Cash From Financing Activities | -749,000USD | 121,027,000USD | -1,554,000USD | 101,709,000USD | 112,221,000USD | 2,889,000USD |
| Issuance Of Capital Stock | 0USD | 69,997,000USD | 0USD | 104,458,000USD | 112,220,000USD | 2,831,000USD |
| Change In Cash | 1,686,000USD | 3,587,000USD | 6,522,000USD | -70,084,000USD | 98,001,000USD | 71,000USD |
| Begin Period Cash Flow | 40,016,000USD | 36,429,000USD | 29,907,000USD | 99,991,000USD | 1,990,000USD | 1,919,000USD |
| End Period Cash Flow | 41,702,000USD | 40,016,000USD | 36,429,000USD | 29,907,000USD | 99,991,000USD | 1,990,000USD |
| Other Cashflows From Financing Activities | -750,000USD | 51,030,000USD | -1,297,000USD | -2,749,000USD | 112,221,000USD | 2,831,000USD |
| Unclassified Investing Cash Flow | — | 2,768,000USD | 116,891,000USD | — | — | — |
| Unclassified Operating Cash Flow | — | — | -3,609,000USD | — | — | — |
| Change To Liabilities | — | — | — | -245,000USD | 798,000USD | 81,000USD |
| Sale Purchase Of Stock | — | — | — | 101,709,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -70,084,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | — | 2,749,000USD | -112,220,000USD | -2,831,000USD |
| Net Borrowings | — | — | — | — | 0USD | 58,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.